Table 3

Quantitative trait loci associated with survival, spleen weight, and WBC count

QTLPeak map location (1 LPR CI)Closest SNPModelLPRR2a (SE)d (SE)
Mleu1.1 42.837 (39-46) rs13476036 +ENU 3.94* 0.125 −0.51 (0.17) 0.62 (0.20) 
Mleu2.1 47.000 (37-55.3) rs3669077 −ENU 2.53 0.082 0.56 (0.15) −0.28 (0.20) 
Mleu11.1 54.044 (50-57) rs13481161 +ENU 2.48 0.081 −0.10 (0.13) −0.64 (0.19) 
Mleu19.1 24.989 (14-46) rs3655407 +ENU 2.99 0.096 0.45 (0.12) 0.13 (0.19) 
MleuX.1 59.634 (49-ter) rs13484113 −ENU 2.26 0.055 0.27 (0.10) — 
Spl6.1 65.000 (53-ter) rs13479087 Interact 2.62 0.036 −0.17 (0.09) 0.18 (0.11) 
Spl6.1 65.000 (53-ter) rs13479087 +ENU 1.82 0.060 0.18 (0.07) −0.15 (0.07) 
Spl6.1 65.000 (53-ter) rs13479087 −ENU 1.05 0.035 −0.17 (0.10) 0.18 (0.10) 
Spl7.1 11.000 (0-20) rs6239372 Covariate 3.13 0.042 −0.20 (0.07) 0.13 (0.08) 
Spl11.1 1.000 (0–6) rs13480834 −ENU 4.24* 0.135 0.38 (0.09) −0.20 (0.13) 
Spl11.2 42.310 (37-54) rs6384104 +ENU 2.47 0.081 −0.15 (0.07) 0.14 (0.07) 
Spl16.1 16.505 (7-31) rs4167843 Interact 2.48 0.034 0.13 (0.08) 0.29 (0.11) 
Spl16.1 16.505 (7-31) rs4167843 +ENU 1.20 0.041 −0.14 (0.07) −0.12 (0.10) 
Spl16.1 16.505 (7-31) rs4167843 −ENU 1.47 0.049 0.13 (0.10) 0.29 (0.13) 
Wbc1.1 24.000 (17-31) rs6206420 +ENU 3.30 0.129 −0.69 (0.20) −0.27 (0.27) 
Wbc15.1 23.879 (16-34) rs13482609 +ENU 2.75 0.109 0.68 (0.19) 0.00 (0.25) 
Wbc19.1 47.000 (36-ter) rs3718687 Covariate 2.85 0.042 0.43 (0.13) 0.21 (0.18) 
QTLPeak map location (1 LPR CI)Closest SNPModelLPRR2a (SE)d (SE)
Mleu1.1 42.837 (39-46) rs13476036 +ENU 3.94* 0.125 −0.51 (0.17) 0.62 (0.20) 
Mleu2.1 47.000 (37-55.3) rs3669077 −ENU 2.53 0.082 0.56 (0.15) −0.28 (0.20) 
Mleu11.1 54.044 (50-57) rs13481161 +ENU 2.48 0.081 −0.10 (0.13) −0.64 (0.19) 
Mleu19.1 24.989 (14-46) rs3655407 +ENU 2.99 0.096 0.45 (0.12) 0.13 (0.19) 
MleuX.1 59.634 (49-ter) rs13484113 −ENU 2.26 0.055 0.27 (0.10) — 
Spl6.1 65.000 (53-ter) rs13479087 Interact 2.62 0.036 −0.17 (0.09) 0.18 (0.11) 
Spl6.1 65.000 (53-ter) rs13479087 +ENU 1.82 0.060 0.18 (0.07) −0.15 (0.07) 
Spl6.1 65.000 (53-ter) rs13479087 −ENU 1.05 0.035 −0.17 (0.10) 0.18 (0.10) 
Spl7.1 11.000 (0-20) rs6239372 Covariate 3.13 0.042 −0.20 (0.07) 0.13 (0.08) 
Spl11.1 1.000 (0–6) rs13480834 −ENU 4.24* 0.135 0.38 (0.09) −0.20 (0.13) 
Spl11.2 42.310 (37-54) rs6384104 +ENU 2.47 0.081 −0.15 (0.07) 0.14 (0.07) 
Spl16.1 16.505 (7-31) rs4167843 Interact 2.48 0.034 0.13 (0.08) 0.29 (0.11) 
Spl16.1 16.505 (7-31) rs4167843 +ENU 1.20 0.041 −0.14 (0.07) −0.12 (0.10) 
Spl16.1 16.505 (7-31) rs4167843 −ENU 1.47 0.049 0.13 (0.10) 0.29 (0.13) 
Wbc1.1 24.000 (17-31) rs6206420 +ENU 3.30 0.129 −0.69 (0.20) −0.27 (0.27) 
Wbc15.1 23.879 (16-34) rs13482609 +ENU 2.75 0.109 0.68 (0.19) 0.00 (0.25) 
Wbc19.1 47.000 (36-ter) rs3718687 Covariate 2.85 0.042 0.43 (0.13) 0.21 (0.18) 

QTL locations and gene effects are shown for survival (MleuX.Y, where X is the chromosome and Y is the number along the chromosome), spleen weight (SplX.Y), and white blood cell count (WbcX.Y).

LPR CI indicates likelihood probability ratio confidence interval; R2, proportion of variance for the model; a, gene effects for the additive genotypic value; d, gene effects for the dominance genotypic value; SE, standard error of the estimate.

*

Significant at the genomewide threshold.

Significant at P = .05.

Significant at the chromosome-wide threshold.

Close Modal

or Create an Account

Close Modal
Close Modal